AstraZeneca (AZN)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4482.00p Today's change: +0.32%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4482.00p 5 day change: +2.24%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4482.00p 6 month change: -1.95%

Contact details

Address: 2 Kingdom Street, London
Phone: +44 (0)20 7604 8000
Fax: +44 (0)20 7604 8151
Website: www.astrazeneca.com

Company information

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

The pay of FTSE 100 bosses fell by nearly a fifth last year on the back of growing investor pressure for restraint.  [...]

3 August 2017
Shares
35
Views
1,563

Investment and trading platform Interactive Investor has revealed its top most-traded for the month of July. [...]

2 August 2017
Shares
9
Views
942

Shares in pharma giant AstraZeneca rose today, after it announced Imfinzi, one of its flagship cancer drugs, had [...]

31 July 2017
Shares
5
Views
758

When defending their companies against hostile takeovers, chief executives usually resort to fairly prosaic and [...]

27 July 2017
Shares
3
Views
422

AstraZeneca shares plunged more than 15 per cent in early trading in London, causing it to become the biggest [...]

27 July 2017
Shares
3
Views
1,260

Pharmaceuticals giants AstraZeneca and GlaxoSmithKline (GSK) will report half-year results this week, and all [...]

23 July 2017
Shares
17
Views
1,350

The chief executive of pharmaceuticals giant AstraZeneca has written to staff to stifle rumours he is planning [...]

21 July 2017
Shares
3
Views
422

Shares in pharmaceutical giant AstraZeneca slid in morning trading after reports suggested its chief executive [...]

13 July 2017
Shares
10
Views
1,737

AstraZeneca today announced the sale of its migraine drug to Germany's Grunenthal. [...]

7 June 2017
Views
228

AstraZeneca today confirmed it priced a three-tranche bond offering totalling $2bn (£1.6bn) yesterday, which is [...]

6 June 2017
Shares
2
Views
310

FTSE 100 pharma giant AstraZeneca has sold the commercial rights to its Seloken heart medicines in Europe for [...]

22 May 2017
Shares
8
Views
213

Shares in AstraZeneca jumped nearly five per cent this morning, boosted by a successful trial of one of its [...]

12 May 2017
Shares
1
Views
697

One of Britain’s top captains of industry breathed a sigh of relief this week when he suggested to me that this [...]

28 April 2017
Shares
12
Views
570

The board of AstraZeneca was left with a bloody nose after nearly 40 per cent of voting shareholders opposed [...]

27 April 2017
Views
310

AstraZeneca said it will turn a corner in the second half of 2017 after facing plummeting revenues as drug patents [...]

27 April 2017
Views
273

Content tagged with "AstraZeneca"